4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Antirheumatic Agents: new trials by email Literature Review of Antirheumatic Agents trials Research Report on Antirheumatic Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rheumatoid Arthritis Memory B Cells and Abatacept Abatacept, DMARDs - Rheumatoid Arthritis | Phase 4 | Completed | NYU Langone Health | 25 | 2019-06-02 | 2024-07-03 |
| A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488 DMARDs, Tocilizumab - Arthritis, Rheumatoid | Phase 4 | Completed | Hoffmann-La Roche | 26 | 2013-01-15 | 2017-06-12 |
| RHYTHM (Formerly Escape II Myocardium) TNF inhibitors, DMARDs - Rheumatoid Arthritis | Phase 4 | Completed | Columbia University | 149 | 2011-10-10 | 2020-11-27 |
| A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs. tocilizumab [RoActemra/Actemra], DMARDs (disease-modifying antirheumatic drugs) - Rheumatoid Arthritis | Phase 4 | Completed | Hoffmann-La Roche | 201 | 2009-10-31 | 2018-03-29 |
Arthritis, Rheumatoid (4) · Cardiovascular Diseases (1)
Hoffmann-La Roche (2) · Columbia University (1) · NYU Langone Health (1)
United States (2) · Brazil (1) · Russia (1)
Gregg Silverman, MD (1) · Joan M Bathon, MD (1) · William Rigby, MD (1)
R01AR050026 (1)